Back

In heart failure patients, is ARNI and SGLT-2 inhibitor use protective against contrast-associated acute kidney injury?

31 August 2026 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Organ dysfunction in heart failure Prevention ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Abdullah Omer Ebeoglu

Health Sciences University Bagcilar Training and Research Hospital, Istanbul (Turkiye)

4 More presentations in this session

Presentation thumbnail
Prevention of heart failure hospitalization based on remote monitoring and early intervention
Doctor D. Marques (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Passive peripheral oedema monitoring reduces recurrent heart failure events in a randomised crossover trial (HF-TRACK).
Doctor T. Castiello (London, GB)
Abstract Slides Video
Presentation thumbnail
Comparative prognostic performance of bmi-indexed and height-indexed appendicular skeletal muscle mass for risk stratification in older patients with heart failure: insights from FRAGILE-HF
Doctor T. Nakade (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Comparison of AI-assisted ECG and clinical risk scores in selecting individuals with type 2 diabetes for screening for asymptomatic heart failure.
Doctor A. Wegrzyn-Witek (Wroclaw, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Organ dysfunction in heart failure

The Event

Event poster

ESC Congress 2026

31 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Impact of renin-angiotensin system inhibitors in patients with heart failure with reduced ejection fraction and advanced chronic kidney disease
29 August 2026
thumbnail
Congress Presentation
SGLT2 inhibitors on the prevention of contrast-induced acute kidney injury in patients with type 2 diabetes after coronary revascularization: a systematic review and meta-analysis
31 August 2025
thumbnail
Congress Presentation
Pre-procedural machine learning model including prior SGLT2 inhibitor therapy improves early risk stratification for contrast-associated kidney injury in acute coronary syndrome
29 August 2026
thumbnail
Congress Presentation
Impact of routine cardiovascular medications on contrast induced nephropathy post percutaneous coronary intervention: a national experience
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources